Kabra Drugs

Kabra_Drugs22 Apr 2024

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Kabra Drugs

Kabra Drugs

Pharmaceuticals

Kabra_Drugs22 Apr 2024

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
23-Jan-2024	BC	Considered holding of Extra-ordinary General Meeting of the shareholders of the Company on February 17, 2024, at 04.30 pm at Shop No. 270, Shastri Market, Indore, Madhya Pradesh - 452 001, India.	17-Feb-2024
05-Feb-2024	BC	KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve This is to inform you that the meeting of the	14-Feb-2024
18-Jan-2024	BC	KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2024 inter alia to consider and approve We are pleased to inform you that the meeting	23-Jan-2024
08-Dec-2023	BC	KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/12/2023 ,inter alia, to consider and approve This is to inform you that a meeting of the	15-Dec-2023
04-Nov-2023	BC	KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2023 inter alia to consider and approve This is to inform you that the meeting of the	13-Nov-2023

No Rights has been declared by Kabra_Drugs

Book Closure

Record Date	Split Date	Purpose
17-Feb-2024	-	Considered holding of Extra-ordinary General Meeting of the shareholders of the Company on February 17, 2024, at 04.30 pm at Shop No. 270, Shastri Market, Indore, Madhya Pradesh - 452 001, India.
14-Feb-2024	-	KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve This is to inform you that the meeting of the
23-Jan-2024	-	KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2024 inter alia to consider and approve We are pleased to inform you that the meeting
15-Dec-2023	-	KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/12/2023 ,inter alia, to consider and approve This is to inform you that a meeting of the
13-Nov-2023	-	KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2023 inter alia to consider and approve This is to inform you that the meeting of the

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Kabra Drugs Ltd ₹7.19(0.00/0.00%)	7.19	+0.00	3.16	33.15	0.00	-3.20
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.01
Total Income	0.00	0.00	0.00	0.00	0.00	0.01
Total Expenditure	0.11	0.13	0.12	0.14	0.06	0.07
PBIDT	-0.11	-0.13	-0.12	-0.14	-0.06	-0.06
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.11	-0.13	-0.12	-0.14	-0.06	-0.06
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.11	-0.13	-0.12	-0.14	-0.06	-0.06
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.11	-0.13	-0.12	-0.14	-0.06	-0.06

EPS (Unit Curr.)	-0.25	-0.31	-0.28	-0.32	-0.14	-0.14
EPS (Adj) (Unit Curr.)	-0.25	-0.31	-0.28	-0.32	-0.14	-0.14
Calculated EPS (Unit Curr.)	-0.25	-0.31	-0.28	-0.32	-0.14	-0.14
Calculated EPS (Adj) (Unit Curr.)	-0.25	-0.31	-0.28	-0.32	-0.14	-0.14
Calculated EPS (Ann.) (Unit Curr.)	-0.99	-1.22	-1.11	-1.30	-0.55	-0.56
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-0.99	-1.22	-1.11	-1.30	-0.55	-0.56
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.39	4.39	4.39	4.39	4.39	4.39
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.39	4.39	4.39	4.39	4.39	4.39
Reserves Total	-5.12	-4.78	-4.60	-4.42	-4.36	-4.19
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-0.73	-0.39	-0.21	-0.03	0.03	0.20
Secured Loans	0.00	0.00	0.00	0.00	0.02	0.05
Unsecured Loans	1.38	1.03	0.90	0.65	0.65	0.65
Total Debt	1.38	1.03	0.90	0.65	0.67	0.70
Total Liabilities	0.65	0.64	0.69	0.62	0.70	0.90
APPLICATION OF FUNDS :
Gross Block	0.00	0.00	0.17	0.17	0.17	0.17
Less : Accumulated Depreciation	0.00	0.00	0.16	0.13	0.09	0.06
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.01	0.04	0.08	0.11
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.60	0.60	1.25	1.25	1.25	1.26
Cash and Bank	0.00	0.00	0.01	0.01	0.01	0.13
Loans and Advances	0.08	0.10	0.10	0.08	0.08	0.09
Total Current Assets	0.68	0.71	1.37	1.35	1.35	1.48
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.05	0.10	0.71	0.79	0.78	0.80
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.05	0.10	0.71	0.79	0.78	0.80
Net Current Assets	0.63	0.61	0.66	0.56	0.56	0.68
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	0.63	0.61	0.67	0.60	0.64	0.79
Contingent Liabilities	0.00	0.00	0.00	0.48	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.00	0.01	0.01	0.01	0.12
Net Cash from Operating Activities	-0.35	-0.13	-0.25	-0.05	-0.18
Net Cash Used In Investing Activities	0.00	0.00	0.00	0.06	0.07
Net Cash Used In Financing Activities	0.36	0.13	0.25	-0.02	0.00
Net Inc./Dec In Cash And Cash Equivalents	0.00	-0.01	0.00	0.00	-0.10
Cash And Cash Equivalents At End Of The Year	0.00	0.00	0.01	0.01	0.01

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

100.00%

**Promoter pledged shareholding 0.00%

About Kabra Drugs Ltd

Kabra Drugs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 3.16 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.11 crores for the quarter ended December 2018. The company management includes , B V Anatha Kumar,Ananthkumar Shilpa,Churchil Durai M Jebastine,KUNIAMUTHUR NANJAPPAN ANAND,Monika Sanwal,A Anitha (Kabra Drugs Ltd) among others.

Chairman

Registered office

270 Shastri Market Indore,,Indore,Madhya Pradesh,452007

FAX :

Background

Incorporation Year1989

Face Value₹10

Market Lot1

How to buy Kabra Drugs shares on nse?

To buy Kabra Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Kabra Drugs share price today?

The Kabra Drugs shares price on nse is Rs.7.19 today.

What is the market cap of Kabra Drugs shares on BSE ?

The company has a market capitalization of Rs.3.16Cr

What is the PE & PB ratio of Kabra Drugs shares ?

PE is 0 and PB is -3.2

What is the 52 Week High and Low of Kabra Drugs shares?

Kabra Drugs stock price high: Rs.7.19 Kabra Drugs stock price low: Rs.3.18